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Fungal infection following placement of ventriculostomy or ventriculoperitoneal (VP) shunt is uncommon. We report the first
case of Alternaria related central nervous system (CNS) shunt infection in a patient with CNS ependymoma manifesting as
leptomeningitis and a spinal intradural mass. This case illustrates the diagnostic and management challenges.
1. Introduction
Infection is a major concern following placement of ven-
triculostomy or ventriculoperitoneal (VP) shunt with rates
reported between 0 and 20%. The infection may result from
contamination of the device during insertion or during
routine care/manipulation and colonization at the insertion
site from skin flora [1]. Central nervous system (CNS) fungal
infections related to VP shunts are uncommon [2–4] and
pose significant diagnostic and management challenges [1,
4]. The CNS fungal infections may manifest acutely with
dire consequences especially in those with altered immune
function such as those in hematologic malignancies and
transplant recipients. However, in other patient populations
the symptoms may be chronic and protean yet cause signifi-
cant debilitation.
2. Case Report
A48-year-oldmale presented in 9/2006 at an outside hospital
with headaches. Magnetic resonance imaging (MRI) of the
brain revealed a posterior fossa mass. He had craniotomy
with biopsy of the mass and histopathology was consistent
with grade II ependymoma. The postoperative course was
complicated by obstructive hydrocephalus that required ven-
triculostomy and one month later an occipital VP shunt
was placed. Cranial radiation therapy was administered
totaling 54 Grays in 30 fractions to the field surrounding
the tumor bed in 10/2006. He did well for a year until he
developed worsening back pain and restaging MRI revealed
diffuse leptomeningeal involvement of the spine. He was
presumed to have drop metastasis and underwent whole
spine radiation with a total dose of 41 Gray in 11/2007. The
brain MRI over the following year revealed slow progression
with extensive leptomeningeal enhancement involving the
perimesencephalic cistern, bilateral foramina of Luschka,
bilateral internal auditory canals, interpeduncular cistern,
prepontine cisterns, quadrigeminal cistern, and right ten-
torium. MRI of the spine demonstrated leptomeningeal
enhancement of the cervicothoracic and distal spinal cord
with a large lumbosacral intrathecal mass consistent with
residual ependymoma or postradiation scar. He was started
on temozolomide in 5/2009.
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Figure 1: ((a) & (b)) Pretreatment MRI images, (c) CSF cytology showing hyphae and inflammatory response, (d) discolored Ommaya
reservoir, and (e) posttreatment MRI.
In June 2009, patient transferred his care to our insti-
tution with the diagnosis of diffuse cranial and spinal lep-
tomeningeal ependymoma with lumbosacral drop metasta-
sis. He was symptomatic with numbness in his right leg
and back pain. He denied headaches, neck stiffness, visual
changes, fever, or chills. He was continued on temozolomide.
A spinal tap in 9/2009 showed cerebral spinal fluid (CSF)
pleocytosis (WBC 436, neutrophils 59%, lymphocytes 17%,
monocytes 12%, and unclassified cells 12%), low glucose
(39mg/dL), and high protein (636mg/dL). Cytology and
cultures (bacterial, fungal, and acid fast bacilli) were negative.
He completed 4 cycles of temozolomide in 12/2009 and
underwent radiation (17Gy) to the lumbosacral spine in
1/2010. He was started on carboplatin and VP-16 in 1/2010 for
progression of leptomeningeal disease and completed 8 cycles
in 8/2010. AVP shunt revisionwas performed in 4/2010 along
with multiple sessions of intracranial shunt programming
for management of hydrocephalus. Between May and July
2010 he started to complain of lower extremity weakness,
urinary incontinence, and developed foot drop. In 9/2010,
MRI of the brain revealed stable leptomeningeal enhance-
ment surrounding the pons, midbrain, and quadrigeminal
cistern. MRI of the spine showed persistent enhancement
of the cervical, thoracic, and lumbar spine and a 9 cm long
enhancing soft tissue mass filling the thecal sac from L3 to S1
(Figures 1(a) and 1(b)).
In September 2010, he had spinal decompressive surgery
for management of L3 to S1 intradural mass that was causing
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symptoms of right leg weakness, urinary incontinence, and
back pain. Intraoperatively, a dense mass consisting of an
inseparable tangle of nerve roots and scant fibrous tissue was
identified. Surprisingly, histopathology displayed necrotic
tissue with severe acute and chronic inflammationwith single
septate hyphae. Culture of the surgical tissue was not sent.
The serum Aspergillus galactomannan antigen, 1,3-beta D-
glucan, Coccidioides immitis serology, Histoplasma antigen,
and Blastomyces serology were negative. CSF obtained in the
first week of October 2010 was as follows: WBC 179, RBC 3,
neutrophils 78%, lymphocytes 10%, monocytes 12%, glucose
73mg/dL, and protein 125mg/dL. The CSF Aspergillus galac-
tomannan antigen, cryptococcal antigen, and Coccidioides
immitis serology were negative. The bacterial, AFB, and fun-
gal cultures were negative. No occult site of fungal infection
was identified on CT scan of sinus, chest, and abdomen.
Voriconazole was initiated in 10/2010 at therapeutic doses
based on body weight. MRI of the brain and spine was
repeated a month later that depicted improvement in the
leptomeningeal enhancement with the exception of the L3-S1
intradural mass, which remained unchanged. By December
2010, the CSF profile improved (WBC 15, neutrophils 3%,
lymphocyte 77%, monocytes 6%, protein 98mg/dL, and
glucose 46mg/dL). MRI of the brain in 2/2011 displayed a
significant decrease/resolution of abnormal leptomeningeal
enhancement. MRI of the spine also showed near resolution
of the cervicothoracic leptomeningeal enhancement, whereas
the intradural filling defect in LS spine was unchanged. A
follow-up spinal tap in February 2011 showed worsening
pleocytosis (WBC 79, neutrophils 18%, lymphocytes 49%,
monocytes 17%, and eosinophils 5%), increased protein
(175mg/dL), and for the first time cytology showed septate
fungal hyphae with morphology suggestive of Alternaria
(Figure 1(c)). The CSF culture eventually grew Alternaria
spp. He was hospitalized and treated with liposomal Ampho-
tericin B (L-Amb) and Voriconazole pending antifungal
susceptibility testing at a reference lab.
All CNS hardware (VP shunt andOmmaya reservoir) was
removed and an external ventricular drain (EVD)was placed.
The Ommaya reservoir was discolored and a moldy black
substance was seen on macroscopic exam (Figure 1(d)). L-
Ambwas stopped due to worsening renal function. A newVP
shunt was placed for chronic obstructive hydrocephalus after
repeated CSF in 3/2011 showed a decline in WBC to 7 cells
andwas negative for fungal growth. Based on the information
from the antifungal susceptibility testing (Table 1), the patient
was maintained on intravenous Voriconazole for one year
from March 2011 with close monitoring of Voriconazole
trough levels (the trough levels on oral formulation were
subtherapeutic despite weight based dosing).
Follow-up MRI indicated no residual brain or cervi-
cothoracic spinal leptomeningeal enhancement (Figure 1(e)).
The L3-S1 spine intradural soft tissue mass has remained
unchanged. CSF analysis from March 2012 showed 2 WBC,
2 RBC, mildly elevated protein, and normal glucose. He was
noted to have improvement in lower extremity weakness;
however, the foot drop persisted. Most recent MRI of the
brain and spine shows no interval change.
Table 1: Antifungal susceptibility.
Antifungal agent MIC (mg/mL)
Amphotericin B 0.54
Itraconazole 0.5
Posaconazole 0.25
Voriconazole 1.00
3. Discussion
Alternaria spp. are dematiaceous hyphomycetes with world-
wide distribution and are commonly found in soil, wood, and
decomposing plant debris [5]. They are also found on intact
human skin and conjunctiva [6]. Alternaria is an emerging
opportunistic pathogen. It has been implicated in aller-
gic rhinosinusitis, asthma, onychomycosis, ocular infections
especially in the setting of contact lens use/ophthalmologic
surgery, cutaneous/subcutaneous infections, especially the
solid organ transplant recipients, and, lastly, invasive disease
in patients with hematologic malignancy [6–9]. Only one
case of fatal Alternaria primary brain abscess has been
reported in a child with chronic granulomatous disease [10].
Central nervous system device related fungal infections
are an uncommon occurrence [2, 3] with themost commonly
reported isolate being Candida spp. [3, 11]. These infections
can be difficult to diagnose and often pose management
challenges.The difficulty in diagnosismay result from the low
yield of culture, low index of suspicion for fungal infection,
and the lack of typical symptoms such as fever, headaches,
neck pain, or nuchal rigidity.
In this report, we have described the clinical course
of an occult fungal leptomeningeal infection caused by
Alternaria spp., in a patient with a CNS malignancy that
required multiple surgical interventions for the management
of obstructive hydrocephalus. This created the setting for
CNS device related infection, as higher infection rates are
reported with secondary shunt surgery [12]. In our patient
it was very difficult to determine the exact time of onset of
infection because typical symptoms or signs of meningitis
were lacking and the findings noted onMRI were considered
asmalignancy related. CSF pleocytosis, elevated protein level,
and low glucose on initial CSF suggested an inflammatory
process; however, microbiologic work-up was negative which
suggested possibility of partially treated malignancy.
The diagnosis of CNS fungal infection can be particularly
challenging as demonstrated by this case.Thefirst sign of fun-
gal infectionwas the histologic observation of solitary hyphae
with acute and chronic inflammation in the intradural mass.
Ultimately, CSF from the Ommaya reservoir grew Alternaria
spp. and concurrently had an elevated CSF eosinophil count.
Although Alternaria has never been reported as the cause of
chronic leptomeningitis, other dematiaceous fungi such as
Scedosporium, Cladophialophora, andWangiella have caused
devastating CNS infections in both immunocompetent and
immunocompromised hosts. Dimorphic fungi such asHisto-
plasma and Coccidioides have been described as a cause of
chronic meningitis. Hagman et al. described case of CNS
Coccidioides immitis infection manifesting as “hyphal form”
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in the brain parenchyma and CSF, especially in the setting of
a VP shunt or Rickham reservoir [13].
Themanagement of infectedCNS shunts is challenging. It
involves appropriate antimicrobial therapy (with reliable pen-
etration into the CSF and brain tissue) targeting the identified
pathogen, removal of the infected CNS shunt, and resection
of infected tissue, which is not always feasible. In our patient,
the initial antifungal agent, Voriconazole, was chosen based
on the histological evidence of “septate hyphae” that sug-
gested the possibility of Aspergillus, although non-Aspergillus
likemoldswere in the differential diagnosis. Voriconazole has
good in vitro activity against Alternaria spp., and the isolate
was sensitive based on MIC breakpoint (Table 1).
Long-term Voriconazole use can be complicated with
problems such as drug related hepatotoxicity and phototox-
icity with risk for skin cancer. Our patient exhibited both
of these side effects with the exception of skin cancer. We
also encountered challenge in maintaining adequate trough
level with oral formulation that was overcome by intravenous
dosing. In vitro, Amphotericin B and Posaconazole have
activity against this pathogen and can be used as second-
line agents. Amphotericin B lipid formulations can lead
to nephrotoxicity, which our patient developed. There is a
paucity of data and recommendations regarding the duration
of antifungal therapy in such situations. We treated our
patient for one year with intravenous Voriconazole at thera-
peutic doses (weight based). Repeated CSF analyses andMRI
of the brain/spine were done to measure treatment response.
At the one year treatmentmark, CSF pleocytosis had resolved
and MRI indicated resolution of the brain/cervicothoracic
leptomeningeal inflammation. However, the lumbar intradu-
ral spine mass remained unchanged. Clinically, the patient
has regained functional capacity, although lower extremity
neurological problems persist.
4. Conclusion
This case description emphasizes the challenges faced in
establishing the diagnosis of a CNS device related fungal
infection and its management in the setting of a CNS
malignancy.
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